TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 DKK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
283
|
324 | |
| Financial expenses |
0
|
830 | |
| Earnings before taxes |
196
|
-382 | |
| EBITDA |
222
|
258 | |
| Total assets |
416
|
9,101 | |
| Current assets |
359
|
9,006 | |
| Current liabilities |
34
|
633 | |
| Equity capital |
382
|
8,468 | |
| - share capital |
65
|
67 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
91.8%
|
93.0% | |
| Turnover per employee |
283
|
324 | |
| Profit as a percentage of turnover |
69.3%
|
-117.9% | |
| Return on assets (ROA) |
47.1%
|
4.9% | |
| Current ratio |
1055.9%
|
1422.7% | |
| Return on equity (ROE) |
51.3%
|
-4.5% | |
| Change turnover |
-30
|
56 | |
| Change turnover % |
-8%
|
-10%
|
21% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.